Cargando…

Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study

BACKGROUND: The Republic of Congo adopted a new anti-malarial treatment policy in 2006, with artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) as the first- and second-line anti-malarial drugs, respectively. Only three clinical studies had been conducted before the policy change. A rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ndounga, Mathieu, Pembe Issamou Mayengue, Casimiro, Prisca Nadine, Koukouikila-Koussounda, Félix, Bitemo, Michel, Diassivy Matondo, Brunelle, Ndounga Diakou, Lee Aymar, Basco, Leonardo K., Ntoumi, Francine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625922/ https://www.ncbi.nlm.nih.gov/pubmed/26511848 http://dx.doi.org/10.1186/s12936-015-0918-6

Ejemplares similares

Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville
por: Ndounga, Mathieu, et al.
Publicado: (2013)

Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections
por: Koukouikila-Koussounda, Felix, et al.
Publicado: (2012)

Clinical Efficacy of Artemether-Lumefantrine in Congolese Children with Acute Uncomplicated Falciparum Malaria in Brazzaville
por: Ndounga, Mathieu, et al.
Publicado: (2012)

Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo
por: Pembet Singana, Brice, et al.
Publicado: (2022)

Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo
por: Mayengue, Pembe Issamou, et al.
Publicado: (2011)

Genetic evidence of regulatory gene variants of the STAT6, IL10R and FOXP3 locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children
por: Koukouikila-Koussounda, Felix, et al.
Publicado: (2013)

Reduction of multiplicity of infections but no change in msp2 genetic diversity in P.falciparum isolates from Congolese children after introduction of artemisin-combination therapies
por: Ibara-Okabande, Rod, et al.
Publicado: (2012)

Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of artemisinin-combination therapy
por: Ibara-Okabande, Rod, et al.
Publicado: (2012)

Genetic diversity of Plasmodium falciparum infection among children with uncomplicated malaria living in Pointe-Noire, Republic of Congo
por: Singana, Brice Pembet, et al.
Publicado: (2019)

Correction to: Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa
por: Ndounga Diakou, Lee Aymar, et al.
Publicado: (2018)

Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa
por: Ndounga Diakou, Lee Aymar, et al.
Publicado: (2017)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
por: Adjei, George O, et al.
Publicado: (2012)

Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
por: Dentinger, Catherine M., et al.
Publicado: (2021)

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)

In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014
por: Paczkowski, Magdalena, et al.
Publicado: (2016)

Beyond genome-wide scan: Association of a cis-regulatory NCR3 variant with mild malaria in a population living in the Republic of Congo
por: Baaklini, Sabrina, et al.
Publicado: (2017)

Molecular surveillance of the Pfmdr1 N86Y allele among Congolese pregnant women with asymptomatic malaria
por: Dossou-Yovo, Louis Regis, et al.
Publicado: (2020)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018
por: Nhama, Abel, et al.
Publicado: (2021)

Evaluation of the Comparative Efficacy and Safety of Artemether-Lumefantrine, Artesunate-Amodiaquine and Artesunate-Amodiaquine-Chlorpheniramine (Artemoclo™) for the Treatment of Acute Uncomplicated Malaria in Nigerian Children
por: Falade, C.O., et al.
Publicado: (2014)

Genetic variability of human pegivirus type 1 (HPgV-1) among Congolese co-infected with hepatitis C virus in Brazzaville, Congo
por: Niama, Roch Fabien, et al.
Publicado: (2023)

Prevalence of SARS-CoV-2 antibodies in the Republic of Congo in mid-2021
por: Niama, Fabien R., et al.
Publicado: (2022)

High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
por: Batchi-Bouyou, Armel Landry, et al.
Publicado: (2021)

An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria
por: Owusu-Agyei, Seth, et al.
Publicado: (2008)

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial
por: Meremikwu, Martin, et al.
Publicado: (2006)

Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2016)

Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
por: Plucinski, Mateusz M., et al.
Publicado: (2017)

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
por: Grandesso, Francesco, et al.
Publicado: (2018)

Adherence to treatment with artemether–lumefantrine or amodiaquine–artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial
por: Banek, Kristin, et al.
Publicado: (2018)

Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers
por: Koko, Victor S., et al.
Publicado: (2022)

Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016
por: Diarra, Youssouf, et al.
Publicado: (2021)

Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar
por: Rakotoarisoa, Malalanandrianina A., et al.
Publicado: (2022)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance
por: Issa, Mahamat Souleymane, et al.
Publicado: (2023)

Malaria epidemiological research in the Republic of Congo
por: Koukouikila-Koussounda, Felix, et al.
Publicado: (2016)

A comparison of the duration of post-treatment protection of artemether-lumefantrine, dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated malaria
por: Bretscher, Michael T, et al.
Publicado: (2014)

Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children
por: Yeka, Adoke, et al.
Publicado: (2014)

Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea
por: Riloha Rivas, Matilde, et al.
Publicado: (2021)

Early Circulation of SARS-CoV-2, Congo, 2020
por: Bonguili, Novy Charel Bobouaka, et al.
Publicado: (2022)

Malaria burden and anti-malarial drug efficacy in Owando, northern Congo
por: Singana, Brice P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1mr98dril90rs9lh1u2koafv1u